PNPLA3 and metabolic dysfunction-associated steatotic liver disease: The results obtained in the Discovery and Validation cohorts have suggested that niacin availability, the primary source of NAD synthesis, may be affected in patients with the PNPLA3-driven genetic predisposition to develop NAFLD and more so in obese ones.